The new pathogenetic mechanisms of the development of nonalcoholic fatty liver disease combined with metabolic syndrome: focus on microRNAs
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 2
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the worldwide most common liver disease. The modern pathogenesis of NAFLD is associated with disorders in the regulation of cellular processes by the microRNAs at the post-transcriptional level, in particular, by miRNA-34a and miRNA-122. Objective — to study the levels of miRNA-34a, microRNA-122 expression to determine their role in the development and progression of NAFLD combined with metabolic syndrome. Materials and methods. The examinations involved 78 patients with NAFLD combined with components of metabolic syndrome. The control group consisted of 30 healthy donors, matched by age and sex. Patients’ examinations included general-clinical examination, laboratory tests (carbohydrate and lipid metabolism parameters), determination of the degree of liver steatosis by ultrasound, and evaluation of expression of miR‑34a and miR‑122 by fluorometric method. Results. The levels of circulating miRNA-34a and 122 in plasma samples of patients with NAFLD significantly exceeded the corresponding values in the control group. An elevated level of miRNA-34a and -122 may be a potential marker for the development of NAFLD. A significant association of the level of expression of miR‑34a with visceral adipose tissue and the index of insulin resistance was determined. The obtained data may indicate the possible effect of miRNA-34a on lipogenesis activation and disturbance of the distribution of adipose tissue. The role of miR‑122 in the lipid metabolism dysregulation toward the increase of fractions of proatherogenic lipoproteins involved in the formation of NAFLD is established. MicroRNA-122 may act 1as a non-invasive marker for the progression of fibrosis in patients with NAFLD with signs of metabolic syndrome. Conclusions. The increased miRNA-34a, miRNA-122 levels can serve as a potential marker of the NAFLD development. In NAFLD patients with the signs of metabolic syndrome, miRNA-122 can be used as a non-invasive marker of fibrosis progression.
Authors and Affiliations
G. D. Fadieienko, I. E. Kushnir, O. Ye. Grindnev, V. M. Chernova, T. A. Solomentseva, Ya. V. Nikiforova, O. G. Kurinna, V. Yu. Galchinska, T. M. Bondar
Keywords
Related Articles
- EP ID EP574834
- DOI 10.30978/MG-2019-2-9
- Views 129
- Downloads 0
The rational choice of drugs for the dyspepsia treatment in an outpatient clinic
Objective — to conduct a comparative evaluation of the clinical efficacy of pantoprazole, aluminium phosphate gel and drotaverine in the treatment of patients with dyspepsia. Materials and methods. The open comparative...
Helicobacter pylori infection among the adults of Vinnytsya region, patients with nonatrophic and atrophic chronic gastritis
Objective — to assess the degree of Helicobacter pylori infection among the adult patients with chronic gastritis (CG) and its relationship with atrophic changes in the gastric mucosa. Materials and methods. The examina...
The visualized colon hyperpneumatosis, accompanied with the developed clinical symptoms, caused by Chilaiditi syndrome and dolichosigma. A clinical case
In the year 1910, Demetrius Chilaiditi described asymptomatic cases that looked like locations of intraabdominal free air at the routine abdominal or chest X-ray examination, which were caused by interposition of the col...
The mechanisms of development of irritable bowel syndrome and treatment of abdominal pain in the light of Rome IV criteria
Objective — to assess the clinical efficacy of Capsumen in patients with irritable bowel syndrome (IBS) with pain syndrome. Materials and methods. The investigation involved 17 patients (7 women and 10 men aged 19 to 52...
Leukemoid reactions in the gastroenterologist’s practice
Leukemic reactions (LR) are abnormal blood reactions similar to leukemic (subleukemic), but they are different in their pathogenesis; LRs never transform into leukemia. The article presents several clinical cases, the co...